Free Webinars, Masterclasses and Podcasts

Watch our on-demand webinars

Pearce IP publishes its masterclasses, webinars and podcasts addressing various aspects of patent and trade mark law and practice in Australia free of charge.

Masterclass: an in-depth analysis of a subject of interest

PiPCast™: a 10 minute weekly sound bite on a “hot topic” in IP law

Other Podcasts: Pearce IP rehosts podcasts (of varying length) featuring its team members on varying subject matter.”

Search our webinars

Featured Image	Details

BioBlast®

Celltrion Applies For EU Approval of CT-P43, Biosimilar to Regeneron’s Eylea® (aflibercept)

Nov 24, 2023

Celltrion revealed in a corporate filing with the Repository of Korea’s Corporate Filings (DART) that it has applied for marketing authorisation in the EU for its CT-P43, biosimilar to Regeneron’s Eylea® (aflibercept) on 23 November 2023. The application is based on...

Enzene Launches Ranibizumab Biosimilar in India

Nov 24, 2023

Express Pharma reported that Enzene Biosciences has launched its biosimilar ranibizumab in India (biosimilar to Genentech’s Lucentis®) for the treatment of neovascular age-related macular degeneration (AMD). This is Enzene’s seventh Indian biosimilar. On 7 September...

Chugai Launches NIH Listed Phesgo® (pertuzumab and trastuzumab) Combination Product in Japan

Nov 22, 2023

Chugai Pharmaceutical announced the Japanese launch of Phesgo®, a subcutaneous combination of pertuzumab and trastuzumab (Genentech’s Perjeta® and Herceptin® respectively) to treat HER2-positive breast cancer and advanced or recurrent HER2-positive colorectal cancer...

See Our BioBlast®

Blog

BioBlast w/e 24 Nov 23

Nov 27, 2023

24 NOV 2023 | Celltrion Applies For EU Approval of CT-P43, Biosimilar to Regeneron’s Eylea® (aflibercept) Celltrion revealed in a corporate filing with the Repository of Korea’s Corporate Filings (DART) that it has applied for marketing authorisation in the EU for its...

Chris Vindurampulle PhD recognised as 2023 MIP Rising Star & Donna Meredith honoured.

Nov 27, 2023

Pearce IP is proud to announce that Executive Patent & Trade Mark Attorney Chris Vindurampulle PhD has been honoured as a Rising Star by Managing IP’s 2023 IP Stars. The MIP Rising Star list recognises the best next generation IP Leaders who have significantly...

BioBlast w/e 17 Nov 23

Nov 20, 2023

16 NOV 2023 | US | Approval Alert: AZ’s Truqap® (capivasertib) plus Faslodex® FDA Approved to Treat Advanced HR-positive Breast Cancer AstraZeneca (AZ) announced the FDA approved its Truqap® (capivasertib) in combination with Faslodex (fulvestrant) for the treatment...

See Our blog

Awards

Chris Vindurampulle PhD recognised as 2023 MIP Rising Star & Donna Meredith honoured.

Nov 27, 2023

Pearce IP dominates 2023 WIPR Leaders lists for Patents and Trade Marks

Aug 8, 2023

We are pleased to announce that 3 Pearce IP leaders are ranked amongst the world’s best patent and trade mark practitioners by WIPR Leaders 2023. Pearce IP’s Executives Naomi Pearce and Chris Vindurampulle PhD are 2 of 8 (ie 25%) market leading Australian...

Naomi Pearce is the 2023 Lawyers Weekly IP Partner of the Year

Jul 21, 2023

We are excited to announce that Naomi Pearce, (CEO, Executive, Lawyer, Patent & Trade Mark Attorney), founder of Pearce IP, was crowned the 2023 Intellectual Property Partner of the Year at the Lawyers Weekly Partner of the Year Awards on 20 July 2023. The...

See Our Awards